Physician profile
Steven J Compton
NPI 1548285901
$40,750.89
in general payments reported to CMS, 2019-2025
15 companies · $11K in 2025
The $11K reported for 2025 was more than what 82% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $4,609 · 2021: $1,624 · 2022: $5,424 · 2023: $3,671 · 2024: $2,193 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,075 · Travel and Lodging: $4,420 · Food and Beverage: $4,284 · Education: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,075.00 |
| Travel and Lodging | $4,419.83 |
| Food and Beverage | $4,284.40 |
| Education | $271.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,177.67 | 2021-2025 | Affera Mapping System, Arctic Front Advance, Na |
| Medtronic Vascular, INC. | $15,523.42 | 2019-2020 | |
| Abbott Laboratories | $5,017.87 | 2019-2025 | Ensite, Aveir, Tacticath Ablation Catheter, Sensor Enabled |
| Biosense Webster, INC. | $1,056.72 | 2019-2025 | Carto 3 |
| Boston Scientific Corporation | $873.33 | 2019-2025 | Watchman Access System, General - Therapies, Farapulse |
| Atricure, INC. | $771.27 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System |
| Cardiva Medical, INC. | $500.00 | 2019 | |
| Impulse Dynamics (USA) INC. | $262.83 | 2023 | Optimizer |
| Biotronik INC. | $221.39 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $122.51 | 2019-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $96.06 | 2021-2024 | |
| Cleerly, INC. | $93.21 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Cook Medical LLC | $17.97 | 2022 | |
| Amgen INC. | $16.64 | 2024 | Repatha |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.